3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
52
Pancreatic Neoplasms
34
Colonic Neoplasms
20
Carcinoma, Hepatocellular
20
Esophageal Neoplasms
15
Neoplasms
14
Breast Neoplasms
12
Gastrointestinal Neoplasms
11
Stomach Neoplasms
10
Liver Neoplasms
10
Rectal Neoplasms
9
Lung Neoplasms
8
Head and Neck Neoplasms
7
Fibrosis
6
Biliary Tract Neoplasms
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Neoplasm, Residual
4
Neoplasm Metastasis
4
Gastrointestinal Stromal Tumors
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Pancreatic Cyst
3
Melanoma
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Cachexia
3
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Diseases
2
Interventions
Gemcitabine
5
130-nm albumin-bound paclitaxel
3
nimotuzumab
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Hematologic Tests
2
Fluorouracil
2
Albumin-Bound Paclitaxel
2
surufatinib
1
napabucasin
1
irinotecan sucrosofate
1
ensituximab
1
Taxes
1
S 1 (combination)
1
Radiofrequency Ablation
1
Paclitaxel
1
Mass Screening
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic cancer, adult
×
Blood Specimen Collection
×
Gastrointestinal
×
Clear all
NCT06760741
2025-01-07
PREVENPANC
Hospital Clinic of Barcelona
Not yet recruiting
900 enrolled